| Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial T Yau, YK Kang, TY Kim, AB El-Khoueiry, A Santoro, B Sangro, I Melero, ... JAMA oncology 6 (11), e204564-e204564, 2020 | 902 | 2020 |
| Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis S Leoni, F Tovoli, L Napoli, I Serio, S Ferri, L Bolondi World journal of gastroenterology 24 (30), 3361, 2018 | 572 | 2018 |
| Serological tests in gluten sensitivity (nonceliac gluten intolerance) U Volta, F Tovoli, R Cicola, C Parisi, A Fabbri, M Piscaglia, E Fiorini, ... Journal of clinical gastroenterology 46 (8), 680-685, 2012 | 328 | 2012 |
| Nivolumab (NIVO)+ ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040. T Yau, YK Kang, TY Kim, AB El-Khoueiry, A Santoro, B Sangro, I Melero, ... Journal of Clinical Oncology 37 (15_suppl), 4012-4012, 2019 | 246 | 2019 |
| Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ... Journal of hepatology 68 (3), 485-492, 2018 | 212 | 2018 |
| The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy PR Galle, F Tovoli, F Foerster, MA Wörns, A Cucchetti, L Bolondi Journal of hepatology 67 (1), 173-183, 2017 | 207 | 2017 |
| Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness U Volta, G Caio, F Tovoli, R De Giorgio Cellular & molecular immunology 10 (5), 383-392, 2013 | 185 | 2013 |
| Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis U Volta, A Granito, C Parisi, A Fabbri, E Fiorini, M Piscaglia, F Tovoli, ... Journal of clinical gastroenterology 44 (3), 186-190, 2010 | 157 | 2010 |
| New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm M Renzulli, M Biselli, S Brocchi, A Granito, F Vasuri, F Tovoli, ... Gut 67 (9), 1674-1682, 2018 | 155 | 2018 |
| Clinical and diagnostic aspects of gluten related disorders F Tovoli, C Masi, E Guidetti, G Negrini, P Paterini, L Bolondi World Journal of Clinical Cases: WJCC 3 (3), 275, 2015 | 147 | 2015 |
| Effect of gluten free diet on immune response to gliadin in patients with non-celiac gluten sensitivity G Caio, U Volta, F Tovoli, R De Giorgio BMC gastroenterology 14, 1-7, 2014 | 116 | 2014 |
| Clinical and immunological features of celiac disease in patients with type 1 diabetes mellitus U Volta, F Tovoli, G Caio Expert review of gastroenterology & hepatology 5 (4), 479-487, 2011 | 109 | 2011 |
| Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale AC Gardini, L Faloppi, S De Matteis, FG Foschi, N Silvestris, F Tovoli, ... European Journal of Cancer 86, 106-114, 2017 | 94 | 2017 |
| Microbiota, NASH, HCC and the potential role of probiotics G Brandi, S De Lorenzo, M Candela, MA Pantaleo, S Bellentani, F Tovoli, ... Carcinogenesis 38 (3), 231-240, 2017 | 92 | 2017 |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017 | 92 | 2017 |
| Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept S De Lorenzo, F Tovoli, MA Barbera, F Garuti, A Palloni, G Frega, ... Scientific reports 8 (1), 9997, 2018 | 91 | 2018 |
| Old and new serological tests for celiac disease screening U Volta, A Fabbri, C Parisi, M Piscaglia, G Caio, F Tovoli, E Fiorini Expert review of gastroenterology & hepatology 4 (1), 31-35, 2010 | 91 | 2010 |
| Experience with regorafenib in the treatment of hepatocellular carcinoma A Granito, A Forgione, S Marinelli, M Renzulli, L Ielasi, V Sansone, ... Therapeutic Advances in Gastroenterology 14, 17562848211016959, 2021 | 86 | 2021 |
| The evolutionary scenario of hepatocellular carcinoma in Italy: an update L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ... Liver International 37 (2), 259-270, 2017 | 80 | 2017 |
| Current guidelines for the management of celiac disease: A systematic review with comparative analysis A Raiteri, A Granito, A Giamperoli, T Catenaro, G Negrini, F Tovoli World journal of gastroenterology 28 (1), 154, 2022 | 74 | 2022 |
Alessandro GranitoAssociate Professor Dep. of Medical and Surgical Sciences, University of Bologna, IRCCS S.OrsolaVerified email at unibo.it
